Literature DB >> 22580762

Towards a xeno-free and fully chemically defined cryopreservation medium for maintaining viability, recovery, and antigen-specific functionality of PBMC during long-term storage.

Julia C Schulz1, Anja Germann, Beatrice Kemp-Kamke, Angela Mazzotta, Hagen von Briesen, Heiko Zimmermann.   

Abstract

Analysis of cryopreserved peripheral mononuclear cells (PBMC) is important for evaluating new vaccines in immune based therapies and in pathogenesis studies. To ensure comparable assay results from different laboratories and points of time, collaborative research in multicenter trials needs reliable and reproducible cryopreservation protocols that maintain cell viability and functionality. Current cryomedia consist largely of fetal bovine serum (FBS), a natural mix of growth factors, cytokines, and undefined compounds. Standardized procedures are not possible, as FBS can affect the antigen-specific T-cell response, the most important parameter in functionality assays. Also, worldwide sample exchange is complicated by the strict import restrictions on FBS, because of transfection risk. After establishing a serum-free cryopreservation protocol that maintains cell viability, recovery and antigen-specific T-cell response of PBMC comparably to FBS-based cryomedia (Germann et al., 2011), the aim of this study was the complete avoidance of animal proteins and products in combination with efficient cryopreservation. As long-term stability of the cryopreservation process is crucial for retrospective evaluation of samples at different points of time, PBMC were analyzed after storage for maximal four weeks and again after approximately six months. The cryopreservation efficiency of the protein-free and fully chemically defined cryomedium was comparable to FBS-medium after storage for few weeks and several months. Directly after thawing, this medium yielded viabilities over 97% and recovery values over 84%. Also, the specific T-cell functionality was preserved. Additionally, short-term and six month cryopreservation gave comparable results. The fully chemically defined medium presented here will increase standardization and reproducibility of analysis in multicenter-studies or in retrospective evaluation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580762     DOI: 10.1016/j.jim.2012.05.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

Review 1.  Adipose Tissue-Derived Stem Cells in Regenerative Medicine.

Authors:  Laura Frese; Petra E Dijkman; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

2.  Toward Optimal Cryopreservation and Storage for Achievement of High Cell Recovery and Maintenance of Cell Viability and T Cell Functionality.

Authors:  Stephanie Angel; Hagen von Briesen; Young-Joo Oh; Marko K Baller; Heiko Zimmermann; Anja Germann
Journal:  Biopreserv Biobank       Date:  2016-10-28       Impact factor: 2.300

Review 3.  Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.

Authors:  Xue Yao; Sandro Matosevic
Journal:  BioDrugs       Date:  2021-08-24       Impact factor: 5.807

4.  Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and Spain.

Authors:  Marie-Paule Vasson; Marie-Chantal Farges; Nicolas Goncalves-Mendes; Jérémie Talvas; Josep Ribalta; Brigitte Winklhofer-Roob; Edmond Rock; Adrien Rossary
Journal:  Immun Ageing       Date:  2013-09-06       Impact factor: 6.400

5.  Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells.

Authors:  J C Neubauer; I Sébastien; A Germann; S C Müller; A Meyerhans; H von Briesen; H Zimmermann
Journal:  Cytotechnology       Date:  2016-11-28       Impact factor: 2.058

6.  Cryopreservation of Human Mucosal Leukocytes.

Authors:  Sean M Hughes; Zhiquan Shu; Claire N Levy; April L Ferre; Heather Hartig; Cifeng Fang; Gretchen Lentz; Michael Fialkow; Anna C Kirby; Kristina M Adams Waldorf; Ronald S Veazey; Anja Germann; Hagen von Briesen; M Juliana McElrath; Charlene S Dezzutti; Elizabeth Sinclair; Chris A R Baker; Barbara L Shacklett; Dayong Gao; Florian Hladik
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.